Yong Ben

Director, Corbus Pharmaceuticals.

Companies

BridgeBio Oncology Therapeutics, Inc.Chief Med & Dev Officer Aug 18, 2025 to now¹
Corbus PharmaceuticalsBoard member Mar 7, 2023 to now²

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

BridgeBio Oncology Therapeutics, Inc. BBOT44,576 shares³$125.7K at $2.82Jul 1, 2026
Corbus Pharmaceuticals CRBP9,383 shares⁴$42.4K at $4.52Sep 14, 2026

As of each latest filing. The line shows shares held over time.

Sep 14, 2026Sold 2,000 shares at $7.84 of Corbus Pharmaceuticals⁴
Jul 1, 2026Shares withheld for tax 1,047 shares at $7.80 of BridgeBio Oncology Therapeutics, Inc.³
May 19, 2026Granted 3,800 shares of Corbus Pharmaceuticals⁵
Apr 1, 2026Shares withheld for tax 1,047 shares at $9.03 of BridgeBio Oncology Therapeutics, Inc.⁶
Mar 10, 2026Granted 46,670 shares of BridgeBio Oncology Therapeutics, Inc.⁷
May 30, 2025Granted 4,800 shares of Corbus Pharmaceuticals⁸
May 30, 2024Granted 2,783 shares of Corbus Pharmaceuticals⁹

The numbers on this page point here. Each one links to the record it came from.